{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus\u00ae Panel Trimethoprim/Sulfamethoxazole (0.06/1.15 - 8/152 mcg/ml)",
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels",
        "MicroScan MICroSTREP plus\u00ae Panel"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K061872",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "June 28, 2006",
    "Summary Letter Received Date": "July 19, 2006",
    "Submission Date": "June 26, 2006",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trimethoprim",
        "Sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Visual reading",
        "Automated instrument reading"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel for antimicrobial susceptibility testing of streptococci to Trimethoprim/Sulfamethoxazole using instrument read capability.",
    "Indications for Use Summary": "For quantitative and/or qualitative determination of antimicrobial susceptibility of aerobic streptococci, including Streptococcus pneumoniae, to Trimethoprim/Sulfamethoxazole, using visual or instrument-based readout.",
    "fda_folder": "Microbiology"
}